SCHEMBL439253

SCHEMBL439253

O=[N+]([O-])C(CO)(CO)CCO

nearest known ligand 0.44

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.44
ALDH1A1 P00352 2/20 0.38
TDP1 Q9NUW8 2/20 0.38
TSHR P16473 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8351999 0.92 LMNA (0.50) LMNAALDH1A1TDP1TSHR
SCHEMBL6927423 0.89 LMNA (0.42) LMNAALDH1A1TDP1TSHR
SCHEMBL28447231 0.85 LMNA (0.41) LMNAALDH1A1TDP1
SCHEMBL28652710 0.83 LMNA (0.52) LMNAALDH1A1TDP1TSHR
SCHEMBL22312 0.83 LMNA (0.52) LMNAALDH1A1TDP1TSHR
SCHEMBL1170692 0.82 LMNA (0.42) LMNAALDH1A1TDP1TSHR
Potassium SCHEMBL8328705 0.80 LMNA (0.50) LMNAALDH1A1TDP1TSHR
Methane SCHEMBL1141018 0.80 LMNA (0.50) LMNAALDH1A1TDP1TSHR
Ammonia Solution, Strong SCHEMBL27791838 0.80 LMNA (0.50) LMNAALDH1A1TDP1TSHR
Nitric Acid SCHEMBL29219452 0.78 LMNA (0.48) LMNAALDH1A1TDP1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4655815-A MICROBIOCIDES CALGON CORPORATION (US) 1987-04-07 US claimed
EP-0196452-A2 Synergistic antimicrobial admixtures containing 2-bromo-2-bromo methylglutaronitrile, process for inhibiting microbial growth and substrates protected against microbial growth CALGON CORPORATION (US) 1986-10-08 EP claimed
JP-6199607-A None JP disclosed
EP-2721101-B1 SINGLE BATH AUTODEPOSITION COATING FOR COMBINATION METAL SUBSTRATES AND METHODS THEREFOR HENKEL AG & CO KGAA (DE) 2020-10-14 EP disclosed
US-10323314-B2 Single bath autodeposition coating for combination metal substrates and methods therefor HENKEL AG & CO. KGAA (DE) 2019-06-18 US disclosed
US-9139456-B2 Chelating compounds and immobilized tethered chelators THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) 2015-09-22 US disclosed
US-9139456-B2 Chelating compounds and immobilized tethered chelators THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) 2015-09-22 US disclosed
US-8895043-B2 Reducing formaldehyde emissions in formal-containing compositions AIR LIQUIDE SANTE (INTERNATIONAL) (FR) 2014-11-25 US disclosed
EP-1402778-B1 Low-emission formaldehyde donor preparations and use thereof AIR LIQUIDE SANTÉ INTERNATIONAL (FR) 2014-10-01 EP disclosed
US-20140234641-A1 SINGLE BATH AUTODEPOSITION COATING FOR COMBINATION METAL SUBSTRATES AND METHODS THEREFOR HENKEL AG & CO. KGAA (DE) 2014-08-21 US disclosed
EP-2721101-A2 SINGLE BATH AUTODEPOSITION COATING FOR COMBINATION METAL SUBSTRATES AND METHODS THEREFOR Henkel AG & Co. KGaA (DE) 2014-04-23 EP disclosed
US-20120061325-A1 CHELATING COMPOUNDS AND IMMOBILIZED TETHERED CHELATORS THE CURATORS OF THE UNIVERSITY OF MISSOURI 2012-03-15 US disclosed
US-20120061325-A1 CHELATING COMPOUNDS AND IMMOBILIZED TETHERED CHELATORS THE CURATORS OF THE UNIVERSITY OF MISSOURI 2012-03-15 US disclosed
US-20050218379-A1 Low-emission formaldehyde donor preparations SCHULKE & MAYR GMBH (DE) 2005-10-06 US disclosed
EP-1579763-A2 Low-emission formaldehyde depot composition Air Liquide Santé (International) (FR) 2005-09-28 EP disclosed
US-20040082473-A1 A formal, especially a hemiformal, and emission-reducing additive which is urea, urea derivative, amino acid, guanidine or guanidine derivative; contains no iodopropynyl compound or 1H-benzimidazol-2-carbamic acid derivative SCHULKE & MAYR GMBH (DE) 2004-04-29 US disclosed
EP-1402778-A1 Low-emission formaldehyde donor preparations and use thereof Air Liquide Santé (International) (FR) 2004-03-31 EP disclosed
JP-H06199607-A INDUSTRIAL BACTERICIDE COMPOSITION CONTAINING 2-BROMO-2-BROMOMETHYL GLUTARONIRILE AND HAVING SYNERGISTIC EFFECT CALGON CORP 1994-07-19 JP disclosed
US-4655815-A MICROBIOCIDES CALGON CORPORATION (US) 1987-04-07 US disclosed
EP-0196452-A2 Synergistic antimicrobial admixtures containing 2-bromo-2-bromo methylglutaronitrile, process for inhibiting microbial growth and substrates protected against microbial growth CALGON CORPORATION (US) 1986-10-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120061325-A1 CHELATING COMPOUNDS AND IMMOBILIZED TETHERED CHELATORS BTD, TTPA, SLC39A7 LMNA 3554/4885ALDH1A1 3904/4885TDP1 2582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.